MELISSA BAUMGARDNER: Open Payments
NPI 1063970366 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 39 payments from 16 companies in 2025. Trend: 2023 $1,067 · 2024 $813 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $83 |
| ABBVIE INC. | 4 | $67 |
| PFIZER INC. | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Viatris Specialty LLC | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Novo Nordisk Inc | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Biogen, Inc. | 1 | $26 |
Products named: Auvelity, CAPLYTA, TRELEGY ELLIPTA, YUPELRI, NURTEC ODT, QULIPTA, REXULTI, Wegovy.
Industry payments across KY — which companies pay providers there.
